Shreepati Pharmaceuticals Pvt Ltd, a active private limited company, was established on 08 September 1995 in Indore, M.P, Madhya Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232MP1995PTC009950. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.46 M.
It upholds a compliant status. Employing 53 professional, Its leadership includes Rajesh Muchhal (Director), Vedant Muchhal (Director), Dhiraj Muchhal (Director). Past directors included Gokuldas Muchhal, Taramani Muchhal. It holds ₹2.75 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 208-Silver Arc Plaza,20/1,New Palasia,Indore, Indore, M.P, Madhya Pradesh.
U24232MP1995PTC009950
009950
08 September 1995
₹0.50 M
₹0.46 M
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Shreepati Pharmaceuticals Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajesh Muchhal | Director | 16 Jun 1999 | Current |
| Vedant Muchhal | Director | 28 Mar 2016 | Current |
| Dhiraj Muchhal | Director | 28 Mar 2016 | Current |
| Ravi Muchhal | Director | 16 Jun 1999 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 04 Feb 2013 | Past |
| Pramod Abcsdd | Director | 19 Jun 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Shreepati Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced significant reduction in revenue, with a 23.13% decrease. The company also saw a substantial fall in profitability, with a 52.76% decrease in profit. The company's net worth Soared by an impressive increase of 12.9%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Shreepati Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹27,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jan 2017 | Others | ₹2.75 Cr | Open |
Explore comprehensive loan charge details -
Shreepati Pharmaceuticals has a workforce of 53 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Shreepati Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shreepati Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Shreepati Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Shreepati Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior. was completed.
The activity A charge with Others amounted to Rs. 27.50 M with Charge ID 100079941 was registered on 30 Jan 2017. was completed.
Progress on Vedant Muchhal was appointed as a Director was appointed as a Director on 28 Mar 2016 & has been associated with this company since 9 years 9 months . was documented.
The activity Dhiraj Muchhal was appointed as a Director was appointed as a Director on 28 Mar 2016 & has been associated with this company since 9 years 9 months . was completed.
Progress on Rajesh Muchhal was appointed as a Director was appointed as a Director on 16 Jun 1999 & has been associated with this company since 26 years 7 months . was documented.
The CIN of Shreepati Pharmaceuticals Pvt Ltd is U24232MP1995PTC009950.
Shreepati Pharmaceuticals Pvt Ltd is headquartered at 208-Silver Arc Plaza,20/1,New Palasia,Indore, Indore, M.P, Madhya Pradesh.
Shreepati Pharmaceuticals Pvt Ltd was incorporated on 08 September 1995.
The current directors of Shreepati Pharmaceuticals Pvt Ltd are
The primary industry of Shreepati Pharmaceuticals Pvt Ltd is Manufacturing.
Shreepati Pharmaceuticals Pvt Ltd is unlisted.
The authorized capital of Shreepati Pharmaceuticals Pvt Ltd is ₹0.50 M, and the paid-up capital is ₹0.46 M.
The compliance status of Shreepati Pharmaceuticals Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX